AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
COMORBIDITY OF SUBSTANCE USE DISORDERS WITH MOOD AND ANXIETY DISORDERS - RESULTS OF THE INTERNATIONAL CONSORTIUM IN PSYCHIATRIC EPIDEMIOLOGY
Authors: MERIKANGAS KR MEHTA RL MOLNAR BE WALTERS EE SWENDSEN JD AGUILARGAZIOLA S BIJL R BORGES G CARAVEOANDUAGA JJ DEWIT DJ KOLODY B VEGA WA WITTCHEN HU KESSLER RC
Citation: Kr. Merikangas et al., COMORBIDITY OF SUBSTANCE USE DISORDERS WITH MOOD AND ANXIETY DISORDERS - RESULTS OF THE INTERNATIONAL CONSORTIUM IN PSYCHIATRIC EPIDEMIOLOGY, Addictive behaviors, 23(6), 1998, pp. 893-907
PATHOPHYSIOLOGY OF PRE-RENAL AZOTEMIA - DISCUSSION
Authors: BLANTZ RC MADIAS NE ZIEGLER T MEHTA RL STEINER R WARD DM MCDONALD B GABBAI FB
Citation: Rc. Blantz et al., PATHOPHYSIOLOGY OF PRE-RENAL AZOTEMIA - DISCUSSION, Kidney international, 53(2), 1998, pp. 512-523
A MULTICENTER SURVEY OF PATIENT CHARACTERISTICS, PRACTICE PATTERNS AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE (ARF)
Authors: LEWIS JL CHERTOW GM PAGANINI EP HIMMELFARB J IKIZLER TA GREENE T MEHTA RL
Citation: Jl. Lewis et al., A MULTICENTER SURVEY OF PATIENT CHARACTERISTICS, PRACTICE PATTERNS AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE (ARF), Journal of the American Society of Nephrology, 8, 1997, pp. 673-673
INTRAVASCULAR ULTRASOUND IDENTIFIES ABNORMALITIES NOT DETECTED BY ANGIOGRAPHY IN ARTERIOVENOUS GRAFTS OF HEMODIALYSIS-PATIENTS
Authors: ARBABZADEH A MEHTA RL MAHMUD E ZIEGLER T DEMARIA AN BHARGAVA V
Citation: A. Arbabzadeh et al., INTRAVASCULAR ULTRASOUND IDENTIFIES ABNORMALITIES NOT DETECTED BY ANGIOGRAPHY IN ARTERIOVENOUS GRAFTS OF HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 718-718
ATTITUDES OF NORTH-AMERICAN NEPHROLOGISTS TOWARDS DIALYSIS (D) MODALITY SELECTION FOR END-STAGE RENAL-DISEASE (ESRD) - AMERICAN RESULTS
Authors: MEHTA RL JUNG B BLAKE P MENDELSSOHN DC
Citation: Rl. Mehta et al., ATTITUDES OF NORTH-AMERICAN NEPHROLOGISTS TOWARDS DIALYSIS (D) MODALITY SELECTION FOR END-STAGE RENAL-DISEASE (ESRD) - AMERICAN RESULTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1021-1021
PROCEEDINGS OF THE 2ND INTERNATIONAL-CONFERENCE ON CONTINUOUS RENAL REPLACEMENT THERAPY - INTRODUCTION
Authors: MEHTA RL
Citation: Rl. Mehta, PROCEEDINGS OF THE 2ND INTERNATIONAL-CONFERENCE ON CONTINUOUS RENAL REPLACEMENT THERAPY - INTRODUCTION, American journal of kidney diseases, 30(5), 1997, pp. 1-1
ACUTE-RENAL-FAILURE IN THE 21ST-CENTURY - RECOMMENDATIONS FOR MANAGEMENT AND OUTCOMES ASSESSMENT
Authors: DUBOSE TD WARNOCK DG MEHTA RL BONVENTRE JV HAMMERMAN MR MOLITORIS BA PALLER MS SIEGEL NJ SCHERBENSKE J STRIKER GE
Citation: Td. Dubose et al., ACUTE-RENAL-FAILURE IN THE 21ST-CENTURY - RECOMMENDATIONS FOR MANAGEMENT AND OUTCOMES ASSESSMENT, American journal of kidney diseases, 29(5), 1997, pp. 793-799
MODALITIES OF DIALYSIS FOR ACUTE-RENAL-FAILURE
Authors: MEHTA RL
Citation: Rl. Mehta, MODALITIES OF DIALYSIS FOR ACUTE-RENAL-FAILURE, Seminars in dialysis, 9(6), 1996, pp. 469-475
PRACTICAL ISSUES IN THE USE OF CONTINUOUS RENAL REPLACEMENT THERAPIES
Authors: MEHTA RL
Citation: Rl. Mehta, PRACTICAL ISSUES IN THE USE OF CONTINUOUS RENAL REPLACEMENT THERAPIES, Seminars in dialysis, 9(2), 1996, pp. 79-79
FLUID MANAGEMENT IN CONTINUOUS RENAL REPLACEMENT THERAPY
Authors: MEHTA RL
Citation: Rl. Mehta, FLUID MANAGEMENT IN CONTINUOUS RENAL REPLACEMENT THERAPY, Seminars in dialysis, 9(2), 1996, pp. 140-144
NUTRITIONAL CONSIDERATIONS IN CONTINUOUS RENAL REPLACEMENT THERAPIES
Authors: MONSON P MEHTA RL
Citation: P. Monson et Rl. Mehta, NUTRITIONAL CONSIDERATIONS IN CONTINUOUS RENAL REPLACEMENT THERAPIES, Seminars in dialysis, 9(2), 1996, pp. 152-160
PROCEEDINGS OF THE INTERNATIONAL-CONFERENCE ON CONTINUOUS RENAL REPLACEMENT THERAPY - NOVEMBER 9-10, 1995 - INTRODUCTION
Authors: MEHTA RL GOLPER T RONCO C
Citation: Rl. Mehta et al., PROCEEDINGS OF THE INTERNATIONAL-CONFERENCE ON CONTINUOUS RENAL REPLACEMENT THERAPY - NOVEMBER 9-10, 1995 - INTRODUCTION, American journal of kidney diseases, 28(5), 1996, pp. 1-1
NOMENCLATURE FOR CONTINUOUS RENAL REPLACEMENT THERAPIES
Authors: BELLOMO R RONCO C MEHTA RL
Citation: R. Bellomo et al., NOMENCLATURE FOR CONTINUOUS RENAL REPLACEMENT THERAPIES, American journal of kidney diseases, 28(5), 1996, pp. 2-7
ANTICOAGULATION STRATEGIES FOR CONTINUOUS RENAL REPLACEMENT THERAPIES- WHAT WORKS
Authors: MEHTA RL
Citation: Rl. Mehta, ANTICOAGULATION STRATEGIES FOR CONTINUOUS RENAL REPLACEMENT THERAPIES- WHAT WORKS, American journal of kidney diseases, 28(5), 1996, pp. 8-14
ACUTE-RENAL-FAILURE IN THE INTENSIVE-CARE UNIT - WHICH OUTCOMES SHOULD WE MEASURE
Authors: MEHTA RL
Citation: Rl. Mehta, ACUTE-RENAL-FAILURE IN THE INTENSIVE-CARE UNIT - WHICH OUTCOMES SHOULD WE MEASURE, American journal of kidney diseases, 28(5), 1996, pp. 74-80
UTILITY OF CONTINUOUS INDIRECT CALORIMETRY IN MEASURING ENERGY-EXPENDITURE IN ICU PATIENTS WITH ACUTE-RENAL-FAILURE (ARF) TREATED WITH CONTINUOUS HEMODIAFILTRATION
Authors: MONSON P PASCUAL MT JOHNSON FW MEHTA RL
Citation: P. Monson et al., UTILITY OF CONTINUOUS INDIRECT CALORIMETRY IN MEASURING ENERGY-EXPENDITURE IN ICU PATIENTS WITH ACUTE-RENAL-FAILURE (ARF) TREATED WITH CONTINUOUS HEMODIAFILTRATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 584-584
INFLUENCE OF C1Q ON THE INTERACTION OF MODEL IMMUNE-COMPLEXES WITH HUMAN PLATELETS
Authors: SLOAND JA MEHTA RL SCHMER G ROSENFELD SI
Citation: Ja. Sloand et al., INFLUENCE OF C1Q ON THE INTERACTION OF MODEL IMMUNE-COMPLEXES WITH HUMAN PLATELETS, Clinical immunology and immunopathology, 76(2), 1995, pp. 127-134
ANTIOXIDATIVE EFFECT OF AJOWAN IN A MODEL SYSTEM
Authors: MEHTA RL ZAYAS JF
Citation: Rl. Mehta et Jf. Zayas, ANTIOXIDATIVE EFFECT OF AJOWAN IN A MODEL SYSTEM, Journal of the American Oil Chemists' Society, 72(10), 1995, pp. 1215-1218
THERAPEUTIC ALTERNATIVES TO RENAL REPLACEMENT FOR CRITICALLY ILL PATIENTS IN ACUTE PENAL FAILURE
Authors: MEHTA RL
Citation: Rl. Mehta, THERAPEUTIC ALTERNATIVES TO RENAL REPLACEMENT FOR CRITICALLY ILL PATIENTS IN ACUTE PENAL FAILURE, Seminars in nephrology, 14(1), 1994, pp. 64-82
ANTIOXIDATIVE EFFECT OF ISUBGOL IN MODEL AND IN LIPID SYSTEM
Authors: MEHTA RL ZAYAS JF YANG SS
Citation: Rl. Mehta et al., ANTIOXIDATIVE EFFECT OF ISUBGOL IN MODEL AND IN LIPID SYSTEM, Journal of food processing and preservation, 18(6), 1994, pp. 439-452
AJOWAN AS A SOURCE OF NATURAL LIPID ANTIOXIDANT
Authors: MEHTA RL ZAYAS JF YANG SS
Citation: Rl. Mehta et al., AJOWAN AS A SOURCE OF NATURAL LIPID ANTIOXIDANT, Journal of agricultural and food chemistry, 42(7), 1994, pp. 1420-1422
SYNTHETIC PEPTIDES OF HUMAN CD4 ENHANCE BINDING OF IMMUNOGLOBULINS TOMONOCYTE MACROPHAGE CELLS .2. MECHANISMS OF ENHANCEMENT/
Authors: MEHTA RL LENERT P ZANETTI M
Citation: Rl. Mehta et al., SYNTHETIC PEPTIDES OF HUMAN CD4 ENHANCE BINDING OF IMMUNOGLOBULINS TOMONOCYTE MACROPHAGE CELLS .2. MECHANISMS OF ENHANCEMENT/, Cellular immunology, 156(1), 1994, pp. 146-154
IDENTIFICATION OF NOVEL HEPARIN-RELEASABLE PROTEINS, AS WELL AS THE CYTOKINES MIDKINE AND PLEIOTROPHIN, IN HUMAN POSTHEPARIN PLASMA
Authors: NOVOTNY WF MAFFI T MEHTA RL MILNER PG
Citation: Wf. Novotny et al., IDENTIFICATION OF NOVEL HEPARIN-RELEASABLE PROTEINS, AS WELL AS THE CYTOKINES MIDKINE AND PLEIOTROPHIN, IN HUMAN POSTHEPARIN PLASMA, Arteriosclerosis and thrombosis, 13(12), 1993, pp. 1798-1805
RENAL REPLACEMENT THERAPY FOR ACUTE-RENAL-FAILURE - MATCHING THE METHOD TO THE PATIENT
Authors: MEHTA RL
Citation: Rl. Mehta, RENAL REPLACEMENT THERAPY FOR ACUTE-RENAL-FAILURE - MATCHING THE METHOD TO THE PATIENT, Seminars in dialysis, 6(4), 1993, pp. 253-259
MATHEMATICAL FORMULATION TO HELP IDENTIFY THE PATIENT AT RISK OF ISCHEMIC TISSUE NECROSIS - A POTENTIALLY LETHAL COMPLICATION OF CHRONIC-RENAL-FAILURE
Authors: LEVIN A MEHTA RL GOLDSTEIN MB
Citation: A. Levin et al., MATHEMATICAL FORMULATION TO HELP IDENTIFY THE PATIENT AT RISK OF ISCHEMIC TISSUE NECROSIS - A POTENTIALLY LETHAL COMPLICATION OF CHRONIC-RENAL-FAILURE, American journal of nephrology, 13(6), 1993, pp. 448-453
Risultati: 1-25 | 26-26